Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma.

Sundahl N, Vandekerkhove G, Decaestecker K, Meireson A, De Visschere P, Fonteyne V, De Maeseneer D, Reynders D, Goetghebeur E, Van Dorpe J, Verbeke S, Annala M, Brochez L, Van der Eecken K, Wyatt AW, Rottey S, Ost P.

Eur Urol. 2019 Jan 19. pii: S0302-2838(19)30010-7. doi: 10.1016/j.eururo.2019.01.009. [Epub ahead of print]

PMID:
30665814
2.

Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.

Vandekerkhove G, Struss WJ, Annala M, Kallio HML, Khalaf D, Warner EW, Herberts C, Ritch E, Beja K, Loktionova Y, Hurtado-Coll A, Fazli L, So A, Black PC, Nykter M, Tammela T, Chi KN, Gleave ME, Wyatt AW.

Eur Urol. 2019 Jan 9. pii: S0302-2838(18)31050-9. doi: 10.1016/j.eururo.2018.12.042. [Epub ahead of print]

PMID:
30638634

Supplemental Content

Loading ...
Support Center